Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStm Grp. Regulatory News (STM)

  • This share is currently suspended. It was suspended at a price of 61.50
  • There is currently no data for STM

Trading Update

30 Nov 2020 07:00

RNS Number : 8397G
STM Group PLC
30 November 2020
 

 

STM Group Plc

("STM" or "the Company" or "the Group")

Trading Update

 

STM, the cross-border financial services provider, today provides the following update on trading for the year ended 31 December 2020, and expectations for 2021 and beyond.

 

In line with current market expectations, the Board continues to expect the Group will deliver revenue of £23.7 million, EBITDA of £3.6 million, and £2.0 million profit before tax for the year to 31 December 2020.

 

The strong recurring revenue base from exisiting business gives the foundation for our future growth and profitability and remains predominantly unchanged despite the significant macro-economic challenges.

 

As part of the 2021 budget planning cycle, the Board has now taken the decision to adopt a more prudent methodology to its guidance for the year ending 31 December 2021 ("FY21") and beyond. This is set against a backdrop of on-going Covid-19 pandemic concerns, as well as very low interest rates and uncertainty in the financial markets. This has resulted in a number of changes to the assumptions being made, predominantly around new business.

 

The predictability and long-standing history of the QROP and company & trust businesses has meant that there are minimal changes to the Board's expectations of performance for these segments. Similarly, the Board has not changed its expectations for the auto-enrolment and flexible annuity products.

 

This revised approach primarily affects the level of new business for our life assurance and SIPP products.

 

In relation to the life assurance businesses, we have made the decision to not include any new policies from EU member states as a result of the continuing uncertainty surrounding Brexit, and what, if any, passporting rights Gibraltar will have after 2020 year-end. In addition, the Board has now assumed that no new short-term life annuities should be included in the Group's FY21 and FY22 expectations given these products are difficult to predict due to their long lead time. This is especially so in the current economic environment although the opportunity and product remain viable.

 

The Board has also now concluded that it would not be prudent to include any growth in the new business run rate for our expatriate SIPP revenue. Similarly, the Board is now assuming new UK SIPP business will be limited to current partnerships and introducers only, with a measured new business volume being generated by them and assuming no revenue from known but as yet untested partnerships.

 

Finally, the IT investments, as well as the acquisition accounting exercise carried out as per IFRS 3 on the Berkeley Burke acquisition earlier in the year, has resulted in an increased amortisation charge, a non-cash item that directly impacts our statutory profit before tax result.

 

We therefore now anticipate revenue growth of circa 7% for FY21 year-on-year, whilst operating expenses are only forecasted to increase marginally and thus enhanced EBITDA margins will be delivered. The improved EBITDA margin is largely as a result of both direct savings and increased operational efficiencies on the back of the IT projects invested in during the year. Further investment is expected in this area which has been reflected in the Board's revised financial expectations.

 

Alan Kentish, CEO of STM Group commented:

 

"The prolongued nature of the Covid-19 pandemic has had a more significant impact than we previously anticipated. This is frustrating but does not greatly affect the strong core existing business which gives us reliable revenue visibility and a stable long term platform to operate from.

 

"In light of previous challenges around new business, the Board has used the 2021 planning cycle to take a more prudent approach to our forward guidance, given the Covid-19 backdrop, Brexit and the various challenges faced by our introducer base.

 

"Notwithstanding the more prudent approach taken, we are confident in a step-change in profit growth for 2021, albeit from the lower rebased profit position for 2020. STM has a stable business model and a strong balance sheet so these short-term challenges, while unwelcome, require that we adjust our timescale not our ambition."

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

For further information, please contact:

STM Group Plc

www.stmgroupplc.com

Alan Kentish, Chief Executive Officer

Tel: Via Walbrook

Therese Neish, Chief Financial Officer

 

 

 

finnCap

www.finncap.com

Matt Goode / Emily Watts - Corporate Finance

Tim Redfern / Richard Chambers - ECM

Tel: +44 (0) 20 7220 0500

 

 

Walbrook

www.walbrookpr.com

Tom Cooper / Paul Vann

Tel: +44 (0) 20 7933 8780

 

Mob: +44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

 

Notes to editors:

 

STM is a multi-jurisdictional financial services group which is listed on the AIM Market of the London Stock Exchange. The Group specialises in the administration of client assets in relation to retirement, estate and succession planning and wealth structuring.

 

Today, the Group has operations in the UK, Gibraltar, Malta, Jersey and Spain. STM has developed a range of pension products for UK nationals and internationally domiciled clients and has two Gibraltar Life Assurance Companies which provide life insurance bonds - wrappers in which a variety of investments, including investment funds, can be held.

 

STM's growth strategy is focussed on both organic initiatives and strategic acquisitions.

 

Further information on STM Group can be found at www.stmgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMZMLLVGGZM
Date   Source Headline
1st Oct 20217:00 amRNSBoard Changes
28th Sep 202110:15 amRNSHolding(s) in Company
20th Sep 202110:46 amRNSHolding(s) in Company
14th Sep 20217:00 amRNSInterim Results & Investor Presentation
12th Aug 20217:00 amRNSTrading Update, Notice of Results & Investor Pres
24th Jun 202111:00 amRNSResult of AGM
24th Jun 20217:00 amRNSAGM Statement
1st Jun 202112:01 pmRNSAnnual Report and Accounts and Notice of AGM
17th May 20217:00 amRNSInvestor Presentation
12th May 20211:40 pmRNSHolding(s) in Company
11th May 20217:00 amRNSFinal Results
10th May 20217:00 amRNSSale of Jersey CTS Business
4th May 202111:45 amRNSHolding(s) in Company
29th Apr 202110:50 amRNSAppeal of Adams v Carey case
16th Apr 20217:00 amRNSDate Change for Results Announcement
1st Apr 202110:57 amRNSAppeal Judgment in Adams v Carey case
24th Mar 20217:00 amRNSSale of Gibraltar CTS & Tax businesses
3rd Feb 20217:00 amRNSTrading Update & Directorate Change
3rd Dec 20204:42 pmRNSHolding(s) in Company
30th Nov 20207:00 amRNSTrading Update
10th Nov 20204:10 pmRNSHolding(s) in Company
6th Nov 20207:00 amRNS£5.5m Credit Facility To Fund M&A Growth Strategy
4th Nov 20207:00 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSTrading Update
21st Sep 20207:00 amRNSAdams V Carey Update
8th Sep 20207:00 amRNSHalf-year Report & Investor Presentation
13th Aug 20201:35 pmRNSAcquisition
6th Aug 20207:00 amRNSTrading Update & Notice of Results
27th Jul 20204:24 pmRNSHolding(s) in Company
17th Jun 20201:00 pmRNSResult of AGM
17th Jun 20207:00 amRNSAGM Trading Update
18th May 202012:13 pmRNSJudgment in favour of Carey in Adams v Carey case
14th May 202012:01 pmRNSAnnual Financial Report & Notice of AGM
28th Apr 20207:00 amRNSFinal Results
15th Apr 20207:00 amRNSNotice of Results
23rd Mar 20208:00 amRNSUpdate to Results Announcement Date
18th Mar 202012:43 pmRNSHolding(s) in Company
10th Mar 20204:16 pmRNSHolding(s) in Company
28th Feb 202010:21 amRNSHolding(s) in Company
28th Feb 20207:00 amRNSTrading Update & Notice of Results
27th Nov 20194:40 pmRNSSecond Price Monitoring Extn
27th Nov 20194:35 pmRNSPrice Monitoring Extension
27th Nov 20197:00 amRNSTrading Update
20th Nov 201910:37 amRNSHolding(s) in Company
18th Oct 20198:30 amRNSHolding(s) in Company
2nd Oct 20197:00 amRNSTPR Authorisation of Carey Workplace Master Trust
10th Sep 20197:00 amRNSHalf-year Report
15th Aug 20199:01 amRNSHolding(s) in Company
9th Aug 20199:16 amRNSHolding(s) in Company
9th Aug 20199:08 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.